ViroCyt, Inc. — Form D
ViroCyt, Inc. of BOULDER, CO, a company, filed a Form D exempt-offering notice with the SEC on 2015-01-14. The offering totals $4.0M, of which $3.5M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2015-01-14
- Form: D
- Accession: 0001562971-15-000002
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $4.0M
- Amount sold: $3.5M
- Remaining: $532K
- Investors: 23
- Date of first sale: 2014-12-31
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-232188
Issuer
- Name: ViroCyt, Inc.
- CIK: 0001562971
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2012
- Address: 2100 CENTRAL AVENUE, BOULDER, CO, 80301
- Phone: (720) 599-3700
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Jack Ball | Director | Longmont, CO |
| Robert Kline | Director | Kennesaw, GA |
| Mark Lupa | Director | Boulder, CO |
| Dan Mitchell | Director | Boulder, CO |
| Kathy Rowlen | Director | Boulder, CO |
| Walter Young | Director | Longmont, CO |
| Robert Kline | Executive Officer | Kennesaw, GA |
| Robert Kline | Promoter | Kennesaw, GA |
Other filings by this issuer (3)
More